FDA Approves RxSight’s Light Adjustable Lens, First IOL To Enable Refractive Correction After Cataract Surgery by Seini Moimoi | Nov 22, 2017 | Portfolio News
Aimmune Therapeutics to Host Investor Symposium on Peanut Allergy Treatment with Leading Expert Allergists on Friday, December 1 by Seini Moimoi | Nov 20, 2017 | Portfolio News
Inozyme Pharma Raises $49 Million in a Series A Financing to Develop Therapies for Rare Diseases Affecting Soft Tissues and Bone by Seini Moimoi | Nov 15, 2017 | Portfolio News
Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer by Seini Moimoi | Nov 14, 2017 | Portfolio News
Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer by Seini Moimoi | Nov 14, 2017 | Portfolio News
